ISPD guidelines for peritoneal dialysis in acute kidney injury: 2020 update (adults).
Cullis B, Al-Hwiesh A, Kilonzo K, McCulloch M, Niang A, Nourse P, Parapiboon W, Ponce D, Finkelstein FO.
Perit Dial Int. 2021 Jan;41(1):15-31. doi: 10.1177/0896860820970834. Epub 2020 Dec 3.
Transglutaminase 2 in human peritoneal dialysis-related peritoneal injury.
Kunoki S, Ikeno M, Tatsukawa H, Sakai Y, Kinashi H, Kamiya K, Suzuki M, Mizuno M, Yamaguchi M, Sasakura H, Morioka Y, Banshodani M, Tawada M, Iwabu M, Ishimoto T, Takeuchi K, Hitomi K, Kawanishi H, Ito Y.
Physiol Rep. 2025 Sep;13(18):e70567. doi: 10.14814/phy2.70567.
C1 inhibitor mitigates peritoneal injury in zymosan-induced peritonitis.
Ozeki T, Mizuno M, Iguchi D, Kojima H, Kim H, Suzuki Y, Kinashi H, Ishimoto T, Maruyama S, Ito Y.
Am J Physiol Renal Physiol. 2021 Jun 1;320(6):F1123-F1132. doi: 10.1152/ajprenal.00600.2020. Epub 2021 Apr 5.
Peritoneal dialysis.
Miller RB, Tassistro CR.
N Engl J Med. 1969 Oct 23;281(17):945-9. doi: 10.1056/NEJM196910232811707.
Establishment of a novel mouse peritoneal dialysis-associated peritoneal injury model.
Yu F, Chen J, Wang X, Cai Q, Luo J, Wang L, Chen K, He Y.
Clin Exp Nephrol. 2022 Jul;26(7):649-658. doi: 10.1007/s10157-022-02208-x. Epub 2022 Mar 30.
STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis.
Marchant V, García-Giménez J, González-Mateo GT, Sandoval P, Tejedor-Santamaria L, Rayego-Mateos S, Ramos R, Jiménez-Heffernan JA, Ortiz A, Raby AC, López-Cabrera M, Ramos AM, Ruiz-Ortega M.
J Pathol. 2025 Oct;267(2):196-212. doi: 10.1002/path.6462. Epub 2025 Aug 14.
A Novel Peritoneal Packing Method for Management of Hyperkalemia During Acute Kidney Injury in Trauma.
Zimmerman EM, Stewart IJ, Graham TL, Kovacs TJ, Guliashvili T, Golobish TD, Ross JD.
Mil Med. 2024 Jul 3;189(7-8):e1432-e1436. doi: 10.1093/milmed/usae018.
Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells-Peritoneal Stroma Interactions.
Terri M, Trionfetti F, Montaldo C, Cordani M, Tripodi M, Lopez-Cabrera M, Strippoli R.
Front Immunol. 2021 Mar 29;12:607204. doi: 10.3389/fimmu.2021.607204. eCollection 2021.
Matrix metalloproteinase-10 deficiency has protective effects against peritoneal inflammation and fibrosis via transcription factor NFkappabeta pathway inhibition.
Ishimura T, Ishii A, Yamada H, Osaki K, Toda N, Mori KP, Ohno S, Kato Y, Handa T, Sugioka S, Ikushima A, Nishio H, Yanagita M, Yokoi H.
Kidney Int. 2023 Nov;104(5):929-942. doi: 10.1016/j.kint.2023.08.010. Epub 2023 Aug 29.
Peritonitis.
Spalding DR, Williamson RC.
Br J Hosp Med (Lond). 2008 Jan;69(1):M12-5. doi: 10.12968/hmed.2008.69.Sup1.28050.
